Featured Article

Technically Speaking - CVS

Names like ESRX and CVS, who distribute and fill prescriptions are of course profiting from the situation. CVS was in decline yesterday along with several other stocks in this space.

More Featured Articles

Sevens Morning Market Report

Sevens Morning Market Report

Good Morning!

Technically Speaking - MYL

Technically Speaking – MYL

The biotech fallout is squarely on MYL’s hands and the stock price has paid… the price. Now could MYL be a buy? Here’s what I see from the technical side.

Sevens Morning Market Report

Sevens Morning Market Report

Good morning!

Technically Speaking - BMY

Technically Speaking – BMY

BMY has been reeling from a well-publicized drug failure.

Smart People, Stupid Oil Quotes

Smart People, Stupid Oil Quotes

Smart people say the darnedest things…